Financial results - NOVAMEDICA SRL

Financial Summary - Novamedica Srl
Unique identification code: 16713043
Registration number: J22/1766/2004
Nace: 8622
Sales - Ron
134.579
Net Profit - Ron
89.953
Employee
4
The most important financial indicators for the company Novamedica Srl - Unique Identification Number 16713043: sales in 2023 was 134.579 euro, registering a net profit of 89.953 euro and having an average number of 4 employees. Firma isi desfasoara activitatea in domeniul Activitati de asistenta medicala specializata having the NACE code 8622.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Novamedica Srl

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR 29.939 42.616 46.852 65.349 66.141 74.521 76.942 107.340 125.429 134.579
Total Income - EUR 30.839 42.640 46.872 65.364 66.156 76.030 77.047 107.349 125.563 134.579
Total Expenses - EUR 10.351 12.282 13.885 18.261 26.589 32.961 29.322 32.815 40.516 43.280
Gross Profit/Loss - EUR 20.489 30.359 32.987 47.103 39.567 43.069 47.725 74.534 85.046 91.299
Net Profit/Loss - EUR 19.620 29.115 32.520 46.466 38.911 42.337 46.941 73.469 83.866 89.953
Employees 1 1 2 2 2 2 2 2 3 4
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales increased by 7.6%, from 125.429 euro in the year 2022, to 134.579 euro in 2023. The Net Profit increased by 6.342 euro, from 83.866 euro in 2022, to 89.953 in the last year.

Check the financial reports for the company - Novamedica Srl

Rating financiar

Financial Rating -
Novamedica Srl

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Novamedica Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Novamedica Srl

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Novamedica Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Novamedica Srl - CUI 16713043

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets 7.013 5.887 4.600 38.849 35.048 25.160 15.686 32.272 30.046 22.259
Current Assets 26.259 35.979 30.659 37.831 42.209 48.244 59.527 71.568 77.062 99.694
Inventories 1.841 0 0 0 0 0 0 0 0 0
Receivables 0 0 376 1.473 3.501 4.697 3.133 6.779 4.534 10.580
Cash 24.418 35.979 30.283 36.359 38.707 43.547 56.394 64.789 72.528 89.114
Shareholders Funds 67 67 32.587 46.532 21.393 20.979 66.006 92.112 102.567 108.597
Social Capital 67 67 67 66 64 63 62 61 61 61
Debts 33.205 41.799 2.673 30.149 56.113 52.671 9.446 11.963 4.542 13.356
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "8622 - 8622"
CAEN Financial Year 8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 99.694 euro in 2023 which includes Inventories of 0 euro, Receivables of 10.580 euro and cash availability of 89.114 euro.
The company's Equity was valued at 108.597 euro, while total Liabilities amounted to 13.356 euro. Equity increased by 6.342 euro, from 102.567 euro in 2022, to 108.597 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Novamedica Srl

Comments - Novamedica Srl

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.